Wen Liu

Wen Liu has extensive experience in regulatory affairs, with a focus on the biopharmaceutical industry. They are currently working as the VP of Regulatory Affairs at Lyell Immunopharma since May 2021. Prior to this, Wen Liu had a role as a Regulatory Consultant, working as a self-employed professional from June 2020. Before venturing into self-employment, they held the position of VP Regulatory Affairs at Nektar Therapeutics starting from April 2019. Wen Liu began their career in 1998 at Genentech, where they served as a Senior Regulatory Program Director.

Wen Liu earned a Doctor of Philosophy (Ph.D.) degree from UC Irvine. No further information about the start and end years or the specific field of study is given.